Peereboom DM - Search Results

1

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial.

Kim IA, Winter KA, Sperduto PW, De Los Santos JF, Peereboom DM, Ogunleye T, Boulter D, Fritz JM, Cho KH, Shin KH, Zoberi I, Choi S, Palmer JD, Liem B, Kim YB, Anderson BM, Thakrar AW, Muanza TM, Kim MM, Choi DH, Mehta MP, White JR. Kim IA, et al. Among authors: peereboom dm. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1391-1401. doi: 10.1016/j.ijrobp.2023.07.019. Epub 2023 Jul 26. Int J Radiat Oncol Biol Phys. 2024. PMID: 37506981 Clinical Trial.

2

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence.

Rowinsky EK, Kaufmann SH, Baker SD, Grochow LB, Chen TL, Peereboom D, Bowling MK, Sartorius SE, Ettinger DS, Forastiere AA, Donehower RC. Rowinsky EK, et al. J Clin Oncol. 1996 Dec;14(12):3074-84. doi: 10.1200/JCO.1996.14.12.3074. J Clin Oncol. 1996. PMID: 8955652 Clinical Trial.

3

Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting.

Doolittle ND, Peereboom DM, Christoforidis GA, Hall WA, Palmieri D, Brock PR, Campbell KC, Dickey DT, Muldoon LL, O'Neill BP, Peterson DR, Pollock B, Soussain C, Smith Q, Tyson RM, Neuwelt EA. Doolittle ND, et al. Among authors: peereboom dm. J Neurooncol. 2007 Jan;81(1):81-91. doi: 10.1007/s11060-006-9209-y. Epub 2006 Jul 21. J Neurooncol. 2007. PMID: 16858513

4

SWOG-9510: evaluation of topotecan in hormone refractory prostate cancer: a Southwest Oncology Group study.

Klein CE, Tangen CM, Braun TJ, Hussain MH, Peereboom DM, Nichols CR, Rivkin SE, Dakhil SR, Crawford ED. Klein CE, et al. Among authors: peereboom dm. Prostate. 2002 Sep 1;52(4):264-8. doi: 10.1002/pros.10118. Prostate. 2002. PMID: 12210486 Clinical Trial.

5

Phase I and pharmacologic study of high doses of the topoisomerase I inhibitor topotecan with granulocyte colony-stimulating factor in patients with solid tumors.

Rowinsky EK, Grochow LB, Sartorius SE, Bowling MK, Kaufmann SH, Peereboom D, Donehower RC. Rowinsky EK, et al. J Clin Oncol. 1996 Apr;14(4):1224-35. doi: 10.1200/JCO.1996.14.4.1224. J Clin Oncol. 1996. PMID: 8648378 Clinical Trial.

6

Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas.

Balmaceda C, Peereboom D, Pannullo S, Cheung YK, Fisher PG, Alavi J, Sisti M, Chen J, Fine RL. Balmaceda C, et al. Cancer. 2008 Mar 1;112(5):1139-46. doi: 10.1002/cncr.23167. Cancer. 2008. PMID: 18246536 Free article. Clinical Trial.

7

Flow cytometry as a diagnostic tool in lymphomatous or leukemic meningitis: ready for prime time?

Ahluwalia MS, Wallace PK, Peereboom DM. Ahluwalia MS, et al. Among authors: peereboom dm. Cancer. 2012 Apr 1;118(7):1747-53. doi: 10.1002/cncr.26335. Epub 2011 Oct 24. Cancer. 2012. PMID: 22025088 Free article. Review.

8

Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.

Doolittle ND, Abrey LE, Ferrari N, Hall WA, Laws ER, McLendon RE, Muldoon LL, Peereboom D, Peterson DR, Reynolds CP, Senter P, Neuwelt EA. Doolittle ND, et al. Clin Cancer Res. 2002 Jun;8(6):1702-9. Clin Cancer Res. 2002. PMID: 12060607

9

Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium.

Doolittle ND, Anderson CP, Bleyer WA, Cairncross JG, Cloughesy T, Eck SL, Guastadisegni P, Hall WA, Muldoon LL, Patel SJ, Peereboom D, Siegal T, Neuwelt EA. Doolittle ND, et al. Neuro Oncol. 2001 Jan;3(1):46-54. doi: 10.1093/neuonc/3.1.46. Neuro Oncol. 2001. PMID: 11305417 Free PMC article.

10

Pre-irradiation 9-amino [20s] camptothecin (9-AC) in patients with newly diagnosed glioblastoma multiforme.

Farray D, Ahluwalia MS, Snyder J, Barnett GH, Cohen BH, Suh JH, Peereboom DM. Farray D, et al. Among authors: peereboom dm. Invest New Drugs. 2006 May;24(3):177-80. doi: 10.1007/s10637-005-2464-5. Invest New Drugs. 2006. PMID: 16086097 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page